Placenta Accreta Clinical Trial
Official title:
Creatine Kinase Versus 3D Doppler for Antenatal Diagnosis of Morbidly Adherent Placenta
Placenta accreta is a potentially life-threatening obstetric condition that requires a multidisciplinary approach to management.Diagnosis of placenta accreta before delivery minimizes potential maternal or neonatal morbidity and mortality. In this study the researchers will evaluate the role and cost effectiveness of biochemical marker as creatine kinase in comparison with 3D Doppler ultrasound in antenatal diagnosis of placenta accreta and its variants in patients with placenta previa totalis.
Abnormal placentation poses a diagnostic and treatment challenge for all providers caring for pregnant women. As one of the leading causes of postpartum hemorrhage, abnormal placentation involves the attachment of placental villi directly to the myometrium with potentially deeper invasion into the uterine wall or surrounding organs. Surgical procedures that disrupt the integrity of uterus, including cesarean section, dilatation and curettage, and myomectomy, have been implicated as key risk factors for placenta accreta(Megier et al., 2000).Prenatal diagnoses of placenta accreta through the use of gray-scale ultrasonography, color Doppler imaging, and magnetic resonance imaging have been reported previously (Chou et al., 1997). Placenta increta and percreta have rarely been diagnosed antepartum, and ultrasonographic findings may provide the only objective evidence of placenta accreta.A biochemical marker for this condition would therefore be useful (Ophir et al., 1999).It is critical to make the diagnosis before delivery because preoperative planning can significantly decrease blood loss and avoid substantial morbidity associated with placenta accreta (Shih et al., 2009). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04579172 -
Conservative Management of Morbidly Adherent Anterior Situated Placenta
|
N/A | |
| Completed |
NCT04593303 -
Internal Iliac Artery Ligation During Management of Placenta Accreta Spectrum
|
N/A | |
| Recruiting |
NCT03638024 -
Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
|
||
| Not yet recruiting |
NCT06100640 -
Paracervical Pouch in Placenta Accreta Spectrum
|
||
| Completed |
NCT05979181 -
Peripartum Cesarean Hysterectomy for Placenta Percreta
|
||
| Recruiting |
NCT04609527 -
Management of Placenta Accreta Spectrum
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06185894 -
The Role of Using Tourniquet in Decreasing Bleeding in Placenta Accreta Spectrum Cases
|
N/A | |
| Completed |
NCT04573452 -
Galectin-3 and Placenta Accreta
|
||
| Not yet recruiting |
NCT03273569 -
PDIUC Protocol for Placental Accreta
|
N/A | |
| Completed |
NCT03707132 -
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
|
||
| Not yet recruiting |
NCT05104177 -
Effectivness of Conservative Techniques in Management of PAS
|
||
| Completed |
NCT02806024 -
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
|
Phase 4 | |
| Active, not recruiting |
NCT02784886 -
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta
|
N/A | |
| Recruiting |
NCT05070689 -
Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS)
|
N/A | |
| Completed |
NCT05813743 -
Detection of Urinary Bladder Wall Involvement in Abnormally Invasive Placenta (AIP) by 3D Ultrasonography
|
N/A | |
| Withdrawn |
NCT04003428 -
Feasibility of HIFU for Management of Placenta Accreta (HIFU-ACCRETA)
|
N/A | |
| Completed |
NCT04161521 -
Conservative Surgical Novel Technique of Placenta Accreta in Menoufia University Hospital
|
N/A | |
| Recruiting |
NCT05139498 -
Conservative Management for PAS Pilot
|
N/A | |
| Not yet recruiting |
NCT03530475 -
Diagnostic Accuracy of Doppler Ultrasound and Role of Uterine Artery Doppler
|
N/A | |
| Recruiting |
NCT05922397 -
Placenta Accreta Spectrum Topographic Classification
|